About Hepcinat LP Ledipasvir 90 mg and Sofosbuvir 400 mg
What is Hepcinat LP?
Hepcinat-LP is a tablet containing two antiviral drugs (Ledipasvir and Sofosbuvir) that together work as a direct-acting antiviral agent that interferes with hepatitis C virus (HCV) replication. This is used to treat patients who have contracted genotype 1 HCV (the most common subtype in the US and the UK).
How is Hepcinat-LP used?
Each pack of Hepcinat LP contains 28 tablets, with each tablet containing Ledipasvir 90mg Sofobuvir 400mg.
Follow your doctors orders exactly, including how much to take, any other drugs to be taken along with it, and when and how often to take it.
Each tablet can be swallowed with a glass of water.
Adverse effects
Hepcinat-LP is generally well tolerated, with very few side effects and most of them mild and temporary.
The most common side effects of Hepcinat-LP are headaches and tiredness.
If you this you are having an allergic reaction to Hepcinat-LP, notify your doctor immediately. Signs may include rash, hives, excessive itching, unusual difficulty breathing, tightness in your chest, or swelling of the mouth, face, lips, or tongue resulting from the use of Hepcinat-LP.
Warnings
You must not take Hepcinat-LP if you are allergic to Ledipasvir or Sofosbuvir or if you are already taking a medicine containing Sofosbuvir.
Before taking Hepcinat-LP you should advise your doctor of the following. Taking Hepcinat-LP in these cases could involve some risk or stop the medicine from working as intended.
if you are pregnant, planning to become pregnant, or are breast-feeding
if you are currently taking any prescription medicines, or non-prescription medicines (including herbal treatments and dietary supplements)
if you have had allergic reactions to medicines, foods, or other substances in the past
if you have kidney or liver problems
Some medicines can interact negatively with Hepcinat-LP.
Simeprevir can increase the risk of ledipasvir and sofosbuvirs side effects
Carbamazepine, oxcarbazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine, St. Johns wort, or tipranavir can decrease the effectiveness of ledipasvir and sofosbuvir
The risk side effects of Digoxin or Rosuvastatin may be increased by the use of ledipasvir and sofosbuvir
Search templates (CTRL+Space)
Search templates (CTRL+Space)
Effective Antiviral Therapy for Hepatitis CHepcinat LP combines two potent active ingredientsLedipasvir and Sofosbuvirto provide targeted treatment for chronic Hepatitis C infection. The medication hinders viral replication, reducing disease progression and supporting liver health. Its use is guided by professional healthcare protocols to ensure the best therapeutic outcome. Consistent adherence to prescribed dosage maximizes the medications benefits.
Simple Dosage and Storage GuidelinesEach box contains 28 tablets, designed for daily oral administration. It is crucial to follow your physicians dosage instructions for Hepcinat LP. For optimal potency, store the medicine at room temperature (25C) in a cool, dry environment, away from direct sunlight. This ensures the medication remains effective throughout the course of treatment.
FAQs of Hepcinat LP Ledipasvir 90 mg and Sofosbuvir 400 mg:
Q: How should I take Hepcinat LP Ledipasvir 90 mg and Sofosbuvir 400 mg?
A: You should take Hepcinat LP exactly as prescribed by your physician, typically one tablet daily. Do not alter the dosage or stop the medication without consulting your doctor.
Q: What is the primary benefit of using Hepcinat LP for Hepatitis C?
A: Hepcinat LP helps to suppress and eliminate the Hepatitis C virus from your body, improving liver function and decreasing the risk of complications from chronic infection.
Q: When should I start treatment with Hepcinat LP?
A: Treatment should begin as soon as recommended by your healthcare provider after Hepatitis C is diagnosed. Early intervention often leads to better health outcomes.
Q: Where should I store Hepcinat LP tablets for optimal effectiveness?
A: Store Hepcinat LP at room temperature (25C) in a cool and dry place, away from moisture and direct sunlight to maintain its efficacy.
Q: What ingredients are present in Hepcinat LP tablets?
A: Each tablet contains Ledipasvir 90 mg and Sofosbuvir 400 mg, both of which are used to inhibit the replication of the Hepatitis C virus.
Q: How does Hepcinat LP combat Hepatitis C?
A: The combination of Ledipasvir and Sofosbuvir works by blocking specific proteins essential for viral multiplication, thus reducing the viruss presence in the body.
Q: Can Hepcinat LP be exported, supplied, and distributed internationally from India?
A: Yes, Hepcinat LP is exported, supplied, and distributed by manufacturers, importers, and traders based in India, following all pharmaceutical regulations.